Cardiovascular-Kidney-Metabolic (CKM) Syndrome , as defined by the AHA, is a systemic disorder characterized by pathophysiological interactions among metabolic risk factors (such as obesity, insulin resistance, dyslipidemia, and hypertension), chronic kidney disease (CKD), and the cardiovascular system, leading to multiorgan dysfunction and a high rate of adverse cardiovascular outcomes [145]
These pleiotropic actions are mediated through a complex network of interconnected molecular pathways, underscoring SFNs value as a multi-targeted agent in oncology and providing a mechanistic basis for its synergy with conventional therapies
A tecnologia LICAPS permite uma melhor biodisponibilidade dos princpios ativos da frmula
The weak GLP1R immunohistochemical staining is compatible with the low GLP1R density seen in autoradiography (Figure 3eg), where the acinar structure cannot be seen because of the low resolution of the technique
H tr chng oxy ha mnh m Glutathione ng vai tr then cht trong vic v hiu ha cc gc t do nhng phn t khng n nh gy tn thng DNA, protein v mng t bo
